| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acetylcholinesterase inhibitors in treatment-resistant psychotic depression
|
Smart, Chris
|
|
2018
|
|
1 |
p. 59-61
|
artikel
|
| 2 |
A manic episode in a patient with stable bipolar disorder triggered by intranasal mometasone furoate
|
Saraga, Michael
|
|
2014
|
|
1 |
p. 48-49
|
artikel
|
| 3 |
A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder
|
Ionescu, Dawn F.
|
|
2016
|
|
1 |
p. 4-12
|
artikel
|
| 4 |
Aripiprazole versus quetiapine in treatment-resistant obsessive–compulsive disorder: a double-blind clinical trial
|
Shoja Shafti, Saeed
|
|
2015
|
|
1 |
p. 32-37
|
artikel
|
| 5 |
Assessment and management of sexual dysfunction in the context of depression
|
Chokka, Pratap R.
|
|
2018
|
|
1 |
p. 13-23
|
artikel
|
| 6 |
Baclofen in the management of cannabis dependence syndrome
|
Imbert, Bruce
|
|
2014
|
|
1 |
p. 50-52
|
artikel
|
| 7 |
Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole
|
Frankel, Joshua S.
|
|
2017
|
|
1 |
p. 29-41
|
artikel
|
| 8 |
Brexpiprazole: so far so good
|
Das, Saibal
|
|
2016
|
|
1 |
p. 39-54
|
artikel
|
| 9 |
Buprenorphine augmentation in the treatment of refractory obsessive–compulsive disorder
|
Liddell, Malcolm B.
|
|
2013
|
|
1 |
p. 15-19
|
artikel
|
| 10 |
Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients
|
Carlborg, Andreas
|
|
2015
|
|
1 |
p. 13-21
|
artikel
|
| 11 |
Clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention service
|
Shaker, Andrew
|
|
2018
|
|
1 |
p. 3-11
|
artikel
|
| 12 |
Comparison of the effects of Sertindole and Olanzapine on Cognition (SEROLA): a double-blind randomized 12-week study of patients diagnosed with schizophrenia
|
Ernst Nielsen, René
|
|
2014
|
|
1 |
p. 4-14
|
artikel
|
| 13 |
Continuing clozapine treatment with lithium in schizophrenic patients with neutropenia or leukopenia: brief review of literature with case reports
|
Aydin, Memduha
|
|
2016
|
|
1 |
p. 33-38
|
artikel
|
| 14 |
Difference of perceptions and evaluation of cognitive dysfunction in major depressive disorder patients across psychiatrists internationally
|
Hammi, Emna El
|
|
2014
|
|
1 |
p. 22-29
|
artikel
|
| 15 |
Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients
|
Fallon, Paul
|
|
2012
|
|
1 |
p. 13-22
|
artikel
|
| 16 |
Drug models of schizophrenia
|
Steeds, Hannah
|
|
2015
|
|
1 |
p. 43-58
|
artikel
|
| 17 |
Editorial
|
Taylor, David
|
|
2012
|
|
1 |
p. 3-3
|
artikel
|
| 18 |
Editorial
|
Taylor, David
|
|
2016
|
|
1 |
p. 3
|
artikel
|
| 19 |
Editorial
|
Taylor, David
|
|
2014
|
|
1 |
p. 3-3
|
artikel
|
| 20 |
Editorial
|
Taylor, David
|
|
2015
|
|
1 |
p. 3-3
|
artikel
|
| 21 |
Editorial for Therapeutic Advances
|
|
|
2011
|
|
1 |
p. 3-3
|
artikel
|
| 22 |
Effectiveness of long-acting antipsychotics in clinical practice : 1. A retrospective, 18-month follow up and comparison between paliperidone palmitate, risperidone long-acting injection and zuclopenthixol decanoate
|
Cordiner, Matthew
|
|
2016
|
|
1 |
p. 22-32
|
artikel
|
| 23 |
Effect of clozapine on immunoglobulin M plasma levels
|
Lozano, Roberto
|
|
2016
|
|
1 |
p. 58-60
|
artikel
|
| 24 |
Effect of epigallocatechin gallate supplementation in schizophrenia and bipolar disorder: an 8-week, randomized, double-blind, placebo-controlled study
|
Loftis, Jennifer M.
|
|
2013
|
|
1 |
p. 21-27
|
artikel
|
| 25 |
Frontotemporal dementia: latest evidence and clinical implications
|
Young, Juan Joseph
|
|
2018
|
|
1 |
p. 33-48
|
artikel
|
| 26 |
Gabapentin treatment in clozapine-induced restless legs syndrome: two cases and a review of the literature
|
Kumar, Vijaya
|
|
2017
|
|
1 |
p. 42-47
|
artikel
|
| 27 |
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
|
Stone, James M.
|
|
2011
|
|
1 |
p. 5-18
|
artikel
|
| 28 |
Head movements during conversational speech in patients with schizophrenia
|
Leask, Stuart John
|
|
2013
|
|
1 |
p. 29-31
|
artikel
|
| 29 |
High-dose prazosin for the treatment of post-traumatic stress disorder
|
Koola, Maju Mathew
|
|
2014
|
|
1 |
p. 43-47
|
artikel
|
| 30 |
High-dose tricyclics potentiation with mirtazapine, lithium and partial sleep-deprivation: why not tricyclics in combination strategies for resistant melancholia?
|
Espárrago-Llorca, Guadalupe
|
|
2012
|
|
1 |
p. 31-33
|
artikel
|
| 31 |
Hypothermia in a patient with Alzheimer’s disease receiving a combination therapy with risperidone and pipamperone
|
Kamp, Daniel
|
|
2016
|
|
1 |
p. 55-57
|
artikel
|
| 32 |
Long-term antipsychotic polypharmacy: how does it start, why does it continue?
|
Grech, Patrice
|
|
2012
|
|
1 |
p. 5-11
|
artikel
|
| 33 |
Melperone in treatment-refractory schizophrenia: a case series
|
Whiskey, Eromona
|
|
2011
|
|
1 |
p. 19-23
|
artikel
|
| 34 |
Memantine in the management of affective recurrences of bipolar disorders after the discontinuation of long-term lithium treatment: three case histories
|
Serra, Giulia
|
|
2014
|
|
1 |
p. 53-55
|
artikel
|
| 35 |
Methylphenidate-induced spontaneous ejaculation
|
Öncü, Bedriye
|
|
2015
|
|
1 |
p. 59-61
|
artikel
|
| 36 |
Neuroleptic malignant syndrome associated with quetiapine and venlafaxine use: a case report and discussion
|
Woods, Gary
|
|
2013
|
|
1 |
p. 53-55
|
artikel
|
| 37 |
Olanzapine, weight change and metabolic effects: a naturalistic 12-month follow up
|
Salviato Balbão, Marina
|
|
2014
|
|
1 |
p. 30-36
|
artikel
|
| 38 |
Oxytocin for frontotemporal dementia: a systematic review
|
Tampi, Rajesh R.
|
|
2017
|
|
1 |
p. 48-53
|
artikel
|
| 39 |
Physical complications in early clozapine treatment: a case report and implications for safe monitoring
|
Patel, Sachin S.
|
|
2011
|
|
1 |
p. 25-29
|
artikel
|
| 40 |
Pica patient, status post gastric bypass, improves with change in medication regimen
|
Tabaac, Burton J.
|
|
2015
|
|
1 |
p. 38-42
|
artikel
|
| 41 |
Plasma prolactin and bone mineral density in patients on long-term risperidone
|
Lozano, Roberto
|
|
2013
|
|
1 |
p. 57-58
|
artikel
|
| 42 |
Poor monitoring of physical health in patients referred to a mood disorders service
|
Lack, David
|
|
2015
|
|
1 |
p. 22-25
|
artikel
|
| 43 |
Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria
|
Igbinomwanhia, Nosa Godwin
|
|
2017
|
|
1 |
p. 3-10
|
artikel
|
| 44 |
Priapism associated with risperidone: a case report, literature review and review of the South London and Maudsley hospital patients’ database
|
Paklet, Lise
|
|
2013
|
|
1 |
p. 3-13
|
artikel
|
| 45 |
QT dynamics during treatment with sertindole
|
Nielsen, Jimmi
|
|
2015
|
|
1 |
p. 26-31
|
artikel
|
| 46 |
Reducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme
|
Mace, Shubhra
|
|
2015
|
|
1 |
p. 4-12
|
artikel
|
| 47 |
Role of psilocybin in the treatment of depression
|
Mahapatra, Ananya
|
|
2017
|
|
1 |
p. 54-56
|
artikel
|
| 48 |
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects
|
Haddad, Peter M
|
|
2014
|
|
1 |
p. 15-21
|
artikel
|
| 49 |
Switching away from pipotiazine palmitate: a naturalistic study
|
Mustafa, Feras Ali
|
|
2017
|
|
1 |
p. 25-28
|
artikel
|
| 50 |
The influence and changes in the dosages of concomitantly used psychotropic drugs associated with the discontinuation of donepezil in severe Alzheimer’s disease with behavioral and psychological symptoms on dementia: a preliminary open-label trial
|
Suzuki, Hidenobu
|
|
2014
|
|
1 |
p. 37-42
|
artikel
|
| 51 |
The influence of switching from oral risperidone to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia
|
Suzuki, Hidenobu
|
|
2012
|
|
1 |
p. 23-29
|
artikel
|
| 52 |
The Nursing Assessment of Medication Acceptance: the reliability and validity of a schizophrenia medication adherence scale
|
Hori, Hikaru
|
|
2017
|
|
1 |
p. 11-16
|
artikel
|
| 53 |
The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review
|
Papanastasiou, Evangelos
|
|
2013
|
|
1 |
p. 33-51
|
artikel
|
| 54 |
The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder
|
Clevenger, Steven S.
|
|
2018
|
|
1 |
p. 49-58
|
artikel
|
| 55 |
The type and prevalence of the use of analgesics among inpatients in a geriatric psychiatry department
|
Østergaard, Pernille Jul
|
|
2016
|
|
1 |
p. 13-21
|
artikel
|
| 56 |
Treatment of adult ADHD: a clinical perspective
|
Geffen, Josh
|
|
2018
|
|
1 |
p. 25-32
|
artikel
|
| 57 |
Varenicline-induced psychotic depressive episode in a patient with bipolar disorder
|
Annagur, Bilge Burcak
|
|
2012
|
|
1 |
p. 35-37
|
artikel
|
| 58 |
Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trust
|
Douglas-Hall, Petrina
|
|
2017
|
|
1 |
p. 17-24
|
artikel
|
| 59 |
When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity
|
Lowe, Penelope
|
|
2018
|
|
1 |
p. 63-70
|
artikel
|
Tijdschrift beschrijving